Kinesiophobia and Balance in Stroke Patients
ConditionStroke
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorIstanbul Physical Medicine Rehabilitation Training and Research Hospital
About this trial
This is a cross-sectional clinical study planned to include 138 stroke patients receiving inpatient treatment at the Istanbul Physical Therapy and Rehabilitation Training and Research Hospital.Data on kinesiophobia (Tampa Kinesiophobia Scale-17) , balance performance (Berg Balance Scale) , balance confidence (Activities-specific Balance Confidence Scale-6) , fear of falling (Falls Efficacy Scale) , pain (VAS) , and mood (HADS) will be collected. Clinical and demographic data, including Brunnstrom stages and Barthel Index, will also be recorded. The relationships between these variables will be analyzed statistically.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Voluntary participation in the study
Male and female patients aged 18-80
History of ischemic or hemorrhagic stroke
Functional Ambulation Scale level 3 or higher
Disqualifiers
History of musculoskeletal surgery within the last year
Trauma, fracture, dislocation, or tumor within the last year
Vestibular system disorder
Additional neurological disease that may affect balance (Parkinson's Disease, Multiple Sclerosis, vestibular system disorder)
Trial population
The source population for this cross-sectional study is the adult patient population with a diagnosis of Stroke who are receiving inpatient physical medicine and rehabilitation services in a public training and research hospital setting in Turkey. Specifically, participants will be recruited from the İstanbul Physical Therapy and Rehabilitation Training and Research Hospital inpatient clinic. This setting provides access to a consecutive sample of individuals with varying degrees of functional deficits who are undergoing an organized rehabilitation program.
Trial design
Design model
Case-only
Time perspective
Cross-sectional
Treatments tested in this trial
Survey using a questionnaire.
Other interventionAll participants in this single cohort will undergo a one-time, cross-sectional assessment. This assessment includes the collection of clinical and demographic data and the administration of scales for kinesiophobia (Tampa Kinesiophobia Scale-17), balance performance (Berg Balance Scale), balance confidence (ABC-6), fear of falling (Falls Efficacy Scale), pain (VAS), and mood (HADS). No intervention is administered.
Treatment groups
138 Participants
are divided into 1 treatment groupGroup A: Inpatient Stroke Survivors1 intervention
Trial outcomes
Primary outcomes
1
Assessment of Kinesiophobia using the Tampa Kinesiophobia Scale-17
The Tampa Kinesiophobia Scale-17 (TKS-17) is a 17-item scale assessing fear of movement. It uses a 4-point Likert scale (1=Strongly disagree to 4=Strongly agree). Items 4, 8, 12, and 16 are reverse-scored. The total score ranges from 17 (minimum) to 68 (maximum). A higher score indicates a higher degree of kinesiophobia.
Time frame
at baseline assessmentSecondary outcomes
1
Berg Balance Scale Score
A 14-item scale assessing postural control. Each item is scored 0 (unable) to 4 (normal performance), with a maximum score of 56.
Time frame
at baseline assessment2
Falls Efficacy Scale Score
A 10-item scale rating confidence in performing activities on a scale from 1 to 10. Total score ranges from 10 (minimum) to 100 (maximum). Higher scores indicate a higher level of fear of falling.
Time frame
at baseline assessment3
Hospital Anxiety and Depression Scale Score
A 14-item scale with 7 items for anxiety and 7 for depression, each scored 0-3. Each subscale (Anxiety, Depression) has a maximum score of 21
Time frame
at baseline assessment4
Barthel Index Score
Assessment of functional independence in activities of daily living.
Time frame
at baseline assessmentSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov